Search

everythinglearnresearchcommunity

for

Search:↓

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

A systematic approach is crucial for managing hair loss in women.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Finasteride effectively treats male hair loss, improving growth and density.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

Demodex mites rarely cause scalp infections leading to hair loss, but when they do, treatment is effective.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Some people's hair loss is caused by multiple factors, with the most common being a mix of AGA and CCCA.

Dupilumab for skin problems might reactivate hair loss in some patients.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Intense pulsed light treatment effectively reduces underarm hair by making hair follicles smaller and extending their resting phase.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Imiquimod cream can rarely cause temporary hair loss.

A woman experienced rapid hair loss after taking albendazole, but it started to improve when she stopped the medication.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Naked hair shafts are significantly associated with scarring hair loss and may help diagnose it, especially when multiple are found.